Here are five notes:
1. Dr. Williams is the chief of hematology and oncology and director of clinical and translational research at the hospital.
2. He is president of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and is the director of its pediatric hematology/oncology fellowship training program.
3. He helped establish Dana-Farber/Boston Children’s gene therapy program and his research focuses on blood stem cells, leukemia and gene therapy.
4. He has completed fellowships at Harvard Medical School, Boston Children’s and Dana-Farber Cancer Institute, all located in Boston.
5. In his new role, Dr. Williams will grow the hospital’s precision medicine efforts and advocate for its research community.
More articles on executive moves:
Henry Ford Health System appoints Annmarie Erickson VP of governance: 3 points
Our Lady of Lourdes Regional Medical Center CEO William Barrow to retire in 2017
12 latest hospital, health system CEO moves
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
